Kestra Advisory Services, LLC Exact Sciences Corp Transaction History

Kestra Advisory Services, LLC

$17.3 Billion
Q3 2024

A detailed history of Kestra Advisory Services, LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Kestra Advisory Services, LLC holds 17,330 shares of EXAS stock, worth $916,930. This represents 0.01% of its overall portfolio holdings.

Number of Shares

17,330

Previous 21,309 18.67%

Holding current value

$916,930

Previous $900,000 31.0%

% of portfolio

0.01%

Previous 0.01%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	SELL	$42.43 - $70.83 $168,828 - $281,832	-3,979 Reduced 18.67%	17,330 $1.18 Million
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $30,336 - $54,506	734 Added 3.57%	21,309 $900,000
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $272,515 - $357,268	4,843 Added 30.78%	20,575 $1.42 Million
Q4 2023 Feb 14, 2024	SELL	$59.06 - $75.72 $92,960 - $119,183	-1,574 Reduced 9.1%	15,732 $1.16 Million
Q3 2023 Nov 09, 2023	BUY	$65.94 - $99.04 $7,319 - $10,993	111 Added 0.65%	17,306 $1.18 Million
Q2 2023 Aug 11, 2023	BUY	$62.68 - $95.05 $9,652 - $14,637	154 Added 0.9%	17,195 $1.61 Million
Q1 2023 May 12, 2023	SELL	$47.19 - $70.77 $372,234 - $558,233	-7,888 Reduced 31.64%	17,041 $1.16 Million
Q4 2022 Jan 31, 2023	BUY	$30.35 - $53.15 $175,665 - $307,632	5,788 Added 30.24%	24,929 $1.23 Million
Q3 2022 Nov 01, 2022	BUY	$31.97 - $49.37 $3,772 - $5,825	118 Added 0.62%	19,141 $622 Million
Q2 2022 Aug 12, 2022	BUY	$35.61 - $76.23 $90,556 - $193,852	2,543 Added 15.43%	19,023 $749,000
Q1 2022 Apr 26, 2022	BUY	$57.56 - $82.54 $253,839 - $364,001	4,410 Added 36.54%	16,480 $1.15 Million
Q4 2021 Jan 20, 2022	SELL	$72.5 - $100.68 $258,752 - $359,326	-3,569 Reduced 22.82%	12,070 $939,000
Q3 2021 Oct 19, 2021	BUY	$90.24 - $124.05 $102,061 - $140,300	1,131 Added 7.8%	15,639 $1.49 Million
Q2 2021 Jul 28, 2021	BUY	$93.66 - $139.27 $175,706 - $261,270	1,876 Added 14.85%	14,508 $1.8 Million
Q1 2021 May 10, 2021	SELL	$116.57 - $155.01 $84,396 - $112,227	-724 Reduced 5.42%	12,632 $1.66 Million
Q4 2020 Jan 20, 2021	BUY	$99.61 - $142.12 $215,954 - $308,116	2,168 Added 19.38%	13,356 $1.81 Billion
Q3 2020 Nov 12, 2020	BUY	$72.92 - $102.01 $815,828 - $1.14 Million	11,188 New	11,188 $1.14 Billion

Others Institutions Holding EXAS

# of Institutions

670

Shares Held

163M

Call Options Held

2.58M

Put Options Held

2.19M

View Full List

About EXACT SCIENCES CORP

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $9.36B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

More about EXAS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Kestra Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Kestra Advisory Services, LLC with notifications on news.

Account

Kestra Advisory Services, LLC Exact Sciences Corp Transaction History